The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective cohort study of the impact of hospital-wide dihydropyrimidine dehydrogenase (DPYD) genotype testing for fluoropyrimidine-based chemotherapy on adverse events and hospital costs.
 
Theodore John Wigle
No Relationships to Disclose
 
Brandi Povitz
Employment - Maple Respiratory (I)
Consulting or Advisory Role - Atheneum (I)
 
Wendy Teft
No Relationships to Disclose
 
Robin Legan
No Relationships to Disclose
 
John Gordon Lenehan
No Relationships to Disclose
 
Markus Gulilat
No Relationships to Disclose
 
Stephanie Nevison
No Relationships to Disclose
 
Justin Kritzinger
No Relationships to Disclose
 
Veera Punaganty
No Relationships to Disclose
 
Denise Keller
No Relationships to Disclose
 
Suhair AlShanteer
No Relationships to Disclose
 
Robin Francis
Stock and Other Ownership Interests - Leap Therapeutics
 
Victoria Siebring
No Relationships to Disclose
 
Sisira Sarma
No Relationships to Disclose
 
Yun-Hee Choi
No Relationships to Disclose
 
Stephen Welch
Honoraria - Amgen; AstraZeneca; Celgene; Ipsen
 
Eric Winquist
Honoraria - Amgen; Bayer; Eisai; Merck; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Medivation (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Ute Schwarz
No Relationships to Disclose
 
Richard B. Kim
No Relationships to Disclose